Kamada Ltd.

NasdaqGS:KMDA Stock Report

Market Cap: US$426.5m

Kamada Future Growth

Future criteria checks 1/6

Kamada is forecast to grow earnings and revenue by 17.4% and 8.7% per annum respectively.

Key information

17.4%

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth25.1%
Revenue growth rate8.7%
Future return on equityn/a
Analyst coverage

Low

Last updated27 May 2026

Recent future growth updates

Recent updates

Seeking Alpha • Jun 02

Kamada: Undervalued, Yet Execution Risks Keep It A Hold

Summary Kamada Ltd. maintains solid demand and profitability, but near-term margin pressures and execution risks justify a hold rating. FDA approval of the in-house RFFIT lab removes a key operational bottleneck, supporting vertical integration and future growth in the rabies franchise. 1Q26 results showed stable revenues ($45.2M, +3% YoY) and a robust 26% EBITDA margin, offset by gross margin compression and shipment timing effects. KMDA trades at a discount to the sector on FWD EV/EBITDA (7.4x vs. 11.6x), but the market discounts margin sustainability and execution risks despite strong forward growth prospects. Read the full article on Seeking Alpha
Seeking Alpha • Oct 19

Kamada secures $22M extension of Canadian supply tender

Kamada (NASDAQ:KMDA) was awarded an extension of an existing tender from the Canadian Blood Services (CBS) for the supply of four IgG products, CYTOGAM®, HEPAGAM®, VARIZIG® and WINRHO® SDF, for an additional three years for an approximate total value of $22M. The award secures the ongoing sales of those products in the Canadian market. The four commercial products, approved by Health Canada and the U.S. Food and Drug Administration were acquired by Kamada in November 2021. CBS manages the Canadian supply of blood products for all Canadian provinces and territories, excluding Quebec. The supply extension secures ongoing sales of approximately $7.5M per year for 2023-2025, with an option to extend for up to additional two years. Commercial manufacturing of CYTOGAM at Kamada’s Israeli manufacturing plant is expected to be initiated during 2023.
Seeking Alpha • Aug 16

Kamada Q2 2022 Earnings Preview

Kamada (NASDAQ:KMDA) is scheduled to announce Q2 earnings results on Wednesday, August 17th, before market open. The consensus EPS Estimate is -$0.02 (-200.0% Y/Y) and the consensus Revenue Estimate is $23.69M (-2.1% Y/Y). Over the last 1 year, KMDA has beaten EPS estimates 25% of the time and has beaten revenue estimates 25% of the time. Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.

Earnings and Revenue Growth Forecasts

NasdaqGS:KMDA - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20282454446N/A2
12/31/20272273737393
12/31/20262072527324
3/31/2026182201626N/A
12/31/2025180201625N/A
9/30/2025175201828N/A
6/30/2025170193240N/A
3/31/2025167163746N/A
12/31/2024161143748N/A
9/30/2024158163242N/A
6/30/2024155151120N/A
3/31/20241501218N/A
12/31/20231438-24N/A
9/30/2023152627N/A
6/30/20231463611N/A
3/31/2023132-21620N/A
12/31/2022129-22529N/A
9/30/2022115-101317N/A
6/30/2022106-1259N/A
3/31/2022107-7-10-5N/A
12/31/2021104-2-13-9N/A
9/30/2021104449N/A
6/30/20211161249N/A
3/31/2021125151823N/A
12/31/2020133171419N/A
9/30/2020134211115N/A
6/30/2020132202023N/A
3/31/2020134231720N/A
12/31/201912722N/A28N/A
9/30/201914335N/A25N/A
6/30/201912526N/A20N/A
3/31/201912426N/A11N/A
12/31/201811422N/A11N/A
9/30/201810211N/A8N/A
6/30/201811013N/A5N/A
3/31/201810912N/A8N/A
12/31/20171037N/A4N/A
9/30/201791-1N/A2N/A
6/30/201788-2N/A2N/A
3/31/201774-8N/A-5N/A
12/31/201677-7N/A2N/A
9/30/201679-4N/A-6N/A
6/30/201676-8N/A-5N/A
3/31/201676-8N/A-5N/A
12/31/201570-11N/A-14N/A
9/30/201569-11N/A-8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: KMDA's forecast earnings growth (17.4% per year) is above the savings rate (3.5%).

Earnings vs Market: KMDA's earnings (17.4% per year) are forecast to grow slower than the US market (18.4% per year).

High Growth Earnings: KMDA's earnings are forecast to grow, but not significantly.

Revenue vs Market: KMDA's revenue (8.7% per year) is forecast to grow slower than the US market (12.7% per year).

High Growth Revenue: KMDA's revenue (8.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if KMDA's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 23:36
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kamada Ltd. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert WassermanBenchmark Company
Andrew FeinH.C. Wainwright & Co.
Anthony PetroneJefferies LLC